PUBLISHER: DataM Intelligence | PRODUCT CODE: 1140693
PUBLISHER: DataM Intelligence | PRODUCT CODE: 1140693
Wound Debridement Products Market size was valued US$ YY million in 2021 and is estimated to reach US$ YY million by 2029, growing at a CAGR of 5.9% during the forecast period (2022-2029).
Wound Debridement is a process to eliminate foreign invaders, dead tissues, and toxic substances from human wounds. Wound Debridement Products products aid in lowering the poisonous materials that prevent the wounds from getting healed.
The global wound Debridement Products Market is driven by the increase in the aging population, rise in prevalence of diabetes and associated wounds, an increasing number of burn injuries, technological advancements in products, awareness programs for wound care treatment and management, growth in obesity levels and reimbursement policies.
The technological advancements in the products are expected to drive the market growth.
The introduction of single-use negative pressure therapy (NPWT), primarily in-home care settings, is gaining traction. Further, the introduction of ultrasonic devices is expected to drive the wound Debridement Products market. Ultrasonic devices offer benefits like the capacity to differentiate between non-viable and viable tissues. These devices aid in destroying biofilms and bacteria without causing damage to blood vessels. Also, on August 13, 2019, Engineers at Heriot-Watt University developed a tiny electronic sensor that will help medics to heal wounds by "listening" to them. The microsensor aids in monitoring the tiny, microscale changes in tissue that are taking place below the bandages.
Moreover, ongoing research activities are expected to boost the market. For instance, in March 2019, a study published online recently in the journal Scientific Reports by a research team at Ohio State University stated that electroceutical bandages could kill the bacteria around a wound, allowing the wounds to heal faster. Thus, technological advancements in the products and a growing number of research activities drive market growth.
However, the high cost of Debridement Products products and the possible complications after undergoing wound debridement products are hampering the market. For instance, complications such as bleeding, removal of healthy tissues by mechanical Debridement Products, and chances of infection through contamination are likely to restrain the market.
The wound debridement products market provides in-depth analysis of the market based on various industry factors such as unmet needs, pricing analysis, supply chain analysis, regulatory analysis etc.
Gels segment is expected to hold the largest market share in the wound debridement products market.
The gels segment accounted for the largest market share in 2021. The segment benefits from the advantages, including no inflammation, reduced bleeding, and safe removal of necrotic tissues without causing infection. Also, research activities using gels are likely to bolster the market. Moreover, increasing cases of surgical wounds or Surgical Site Infection (SSI) among patients and rising incidence of chronic wounds, especially diabetic foot ulcers, are among the major factors contributing to the segment growth. For instance, CS-based hydrogels have been intensively engaged in wound healing since they are biocompatible and present activity against pathogenic microorganisms. Ferreira et al. developed and characterized a CS gel system associated with chlorhexidine (2% and 4%). This hydrogel system's antibacterial properties and healing activity showed 100% inhibition of bacterial growth when strain S. aureus was applied. Therefore, there is an increase in the demand for the gel. Thus, from the above statements, the market segment is expected to hold the largest market share in the forecast period.
North American region is expected to hold the largest market share in the global wound debridement products market.
North America accounted for the largest market share in 2021. Owing to the product innovations, an increasing number of wound cases, increasing healthcare spending, and the growing aging population in this region are the factors to drive in the forecast period. For instance, the National Institute of Health has estimated that 3% of the population 65 years and above would have a wound at some time. An even higher incidence rate is expected, owing to the traumatic injuries and ulcers endemic in resource-poor countries to other regions. Thus, the rising number of wounds is driving the market.
Moreover, the ongoing research activities for wound management by the key players in the region are expected to boost the market. A study published on August 14, 2019, in the open-access journal PLOS ONE by Brennan Spiegel of Cedars-Sinai Health System and colleagues found that therapeutic virtual reality (VR) is emerging as an active, non-pharmacological treatment modality for pain, anxiety disorders, and distract patients during wound care. Thus, the presence of ongoing research activities is driving the market. Thus, from the above statements, the North American region is expected to hold the largest market share in the forecast period.
Major key players in the wound debridement products market are B. Braun Melsungen AG, Acelity L.P. Inc., Smith & Nephew, Coloplast A/S, ConvaTec Group, Paul Hartmann, Molnlycke Health Care, Lohmann & Rauscher, Medline Industries, and Integra Lifesciences.
B. Braun is a German manufacturer of medical and pharmaceutical devices. The B. Braun product line includes 5,000 items, 95 percent of which are manufactured by the company. The company's product portfolio includes infusion, nutrition, pain therapy products, infusion pumps and systems, surgical instruments, suture materials, hip and knee implants, dialysis equipment and accessories, ostomy, disinfection, and wound care products. The company operates its business through five divisions: hospital care, Aesculap, B. Braun Avitum, out-patient market (OPM) and other sales. B. Braun has a presence in 64 countries and develops products in 18 therapy fields of the healthcare industry.
Askina Gauze Compress, sterile: Askina Gauze Compress is a sterile gauze compress designed with cut edges folded. It is made of 100% cotton.
The global wound debridement products market report would provide an access to an approx. 45+market data table, 40+figures